Authors
Loading...
Engineering CAR T cells from induced pluripotent stem cells improves differentiation and reduces innate skewing in B cell lymphomas, suggesting new immunotherapy avenues.
Yun et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: